More than an ounce of marijuana laced with the deadly synthetic narcotic fentanyl was among the drugs seized Friday morning after the traffic stop in Middleburg, according to the Clay County Sheriff’s Office.
Once Labour Day is safely in the rearview mirror, it’s cable-knit and copious cups of PSLs all the time because — it’s fall, y’all.
Cringe aside, Canadian autumn is one of the best seasons of the year. As fall foliage morphs from summertime greens to moody reds and oranges; pair the visual beauty with a hot beverage and oversized sweater and you’re ready for a walk in the woods.
And while the shorter days and crisp air might have you craving a cozy afternoon nesting on the couch and binging the new LOTR, we recommend saving those melancholic moping days for November. If camping is more your speed, make sure to familiarize yourself with the rules of camping with weed in Canada.
Grab your sneakers or hikers and pick up a couple of these sativa-dominant cannabis products for an energizing autumn walk, perfect for pumpkin spice season. Before long, you’ll be able to see your breath with every huff you make, so make the most of the fall months of 2022 while you can.
Here are seven sativa-dominant cannabis products you can buy across Canada this fall:
Apricot Jelly 510 Thread Cartridge
Licensed producer: BZAM Cannabis
Potency: THC, 82.00 – 88.00% | 820.00 – 880.00 mg/g
Two of the best things about the Apricot Jelly 510 cart from -ness are its uplifting effects and smooth inhale. It’s as potent as it is flavourful, too, and will have you considering jogging up those inclines during your hike rather than leisurely walking. Expect unmistakable flavours of stone fruit, including apricot, obviously, as well as citrus, from the blend of caryophyllene and limonene terps.
Where my terps at? The highest-terpene strains in Canada right now
It’s no secret that a common consumer frustration with 510 carts is how easily they clog, making it difficult to pull in that delicious vapour. Well, slide this Apricot Jelly into the Winner list for its utilization of the brand’s No Burn Technology, which honours that OG terpene taste while being incredibly smooth and consistent.
Sativa 20% Plus Pre-Roll
Brand: Weed Me
Licensed producer: Weed Me
Potency: THC 29.00 – 35.00% | 290.00 – 350.00 mg/g
A 10-pack of these super strong sativa pre-rolls will leave you with more than enough to share, so bring your buds on the trail. Each pre-rolled joint is packed with 0.35 grams of milled flower that’ll kick you into gear. Weed Me has done its due diligence to put the consumer’s enjoyment first. They use lightweight paper cones that shouldn’t canoe or not need to be relit.
It may feel a bit elitist to smoke a joint that’s been rolled on your behalf if you’re used to rolling your own. But trust us, pre-rolls are a super convenient way to blaze when you’re on the go. Just make sure you light up in designated smoking areas if you’re on a trail, and of course, be considerate and don’t toss your roach where animals might eat it.
Brand: THC Kiss
Licensed producer: THC Biomed
Potency: THC, 9.00 – 10.00 mg
This isn’t one of those homemade weed cookies that you attempted to bake in your younger years. THC Kiss based out of Kelowna, B.C. has managed to whisk up a delicious sweet treat that has 10mg of sativa-dominant THC.
These cookies are sold as singles and have a distinct and warming cinnamon flavour — a spice that always feels more appropriate come fall.
If you’re new to the world of legal edibles, remember to start low and go slow. Edibles hit differently than cannabis flower and it’s totally ok to start with a quarter of a cookie, wait a few hours and then up your dose if you want or need something more.
Omega CBD Softgels
Licensed producer: Breathing Green Solutions
Potency: THC, 1.00 mg/capsule, CBD, 23.00 – 30.00 mg/capsule
While edibles like cookies and gummies are pretty easy to carry and consume, softgels and oils are the ultimate discreet method for dosing under the radar. Omega’s CBD soft gels are primarily CBD with 23 – 30 mg per capsule and just 1 mg of sativa-forward THC.
Still, if you’re heading outside to marvel at the changing fall colours, these soft gels will relax your body and lift you up without making you feel overly high.
Ghost Train Haze Flower
Brand: Station House
Licensed producer: Sensi Brands
Potency: THC, 18.00 – 22.00% | 180.00 – 220.00 mg/g
Ghost Train Haze is a skunky sativa contender that’s energizing in all the right ways. This cultivar is the love child of Ghost OG and Neville’s Wreck and has buds that grow incredibly dense, unlike a typical sativa flower.
Star signs and cannabis strains: October 2022 horoscopes
This heavy-hitter will be energizing for some, depending on tolerance, and could even help with depression and pain. Sativa lovers note feelings of euphoria and stamina. This Ontario-grown bud includes terps like beta-caryophyllene, humulene and myrcene, so expect your mouth to quickly recognize those earthy and floral tastes with a touch of citrus.
Sour Diesel Shatter
Licensed producer: Voyage Cannabis
THC: 72.00 – 80.00% | 720.00 – 800.00 mg/g
If you’re into that mouth-puckering taste of gas and tang, Sour Diesel has got to be on your radar. Rad has made the popular strain into a shatter using a hydrocarbon extraction process and the final product is such a perfectly brittle texture with a golden hue.
You’re likely not bringing a dab rig on a hike, but you can certainly use a dab pen with this distillate, and if you’re a heavy consumer this shatter will go a long way in your device. It’s also fast-acting, so you can expect to feel those cerebral and euphoric effects pretty quickly, so figure out when to dose yourself accordingly.
Ginger Ale Galaxy
Brand: Deep Space
Licensed producer: Tweed Inc.
Potency: THC, 10.00 mg
Weed drinks are a modern consumption method that is enjoyable and familiar. There are a number of tasty sativa-dominant beverages in Canada this fall and there’s something so nostalgic about the old-school flavours that scream stomping-through-piles-of-leaves-at-recess that it’s hard not to be drawn to them as a legal adult.
One of those throwbacks is Ginger Ale, which is enjoyable and refreshing for any outdoor adventure. Tweed is responsible for Deep Space, a strong 10mg OG drink in the Canadian weed beverage realm, and has recently released a few different options. The Ginger Ale Galaxy, which packs 10mg of THC per 222ml can, has a bit of a classic weed taste, but with a recognizable ginger ale finish.
Biopharmaceutical Research Co., one of seven cultivators licensed by the U.S Drug Enforcement Administration to grow cannabis primarily for research purposes, closed a $20 million Series A funding round.
According to a news release, the Castroville, California-based company plans to use the venture-capital proceeds to:
- Scale operations.
- Expand product offerings.
- Conduct sponsored research.
- Execute its go-to-market strategy.
Intrinsic Capital Partners led the funding round, with participation from Argonautic Ventures, Achari Ventures, AFI Capital Partners, Delta Emerald Ventures, Self Health America and several family offices.
Biopharmaceutical Research (BRC) was among a handful of companies awarded cannabis bulk manufacturing licenses by the DEA in 2021.
Until then, only the University of Mississippi – aka the National Center for Development of Natural Products – was registered by the DEA for cannabis cultivation for research purposes.
“Receiving our DEA Schedule I registration in 2021 allowed us to significantly advance our research capabilities, optimize our cannabis growing operation, and produce novel cannabis-derived products in a federally compliant manner,” Biopharmaceutical CEO George Hodgin said in a statement.
“This significant new financial infusion will further accelerate our ability to grow as a business, while establishing BRC as an industry leader.”
Researchers wishing to work with DEA-licensed bulk manufacturers such as BRC must also attain DEA approval to conduct cannabis studies.
Like, Comment, Subscribe !!! Watch in HD
Infographic Animation – Cannabis / Marijuana Drugs Effects (GANJA)
NO DRUGS PLEASE !!!
New research shows that LSD and psilocybin might help your brain shift gears between dynamic activity states
Contrary to myths that psychoactive drugs fry your brain, new research published yesterday (October 3) in Nature Communications has found that some hallucinogens may enable more dynamic mental function.
Scientists from Weill Cornell Medicine reviewed recordings from fMRI scans that suggest these substances essentially flatten the landscape of your brain, making it easier to jump between tasks.
Adults in the study group required less mental energy to shift between different modes of activity after using LSD or psilocybin (the psychoactive compound in magic mushrooms).
The research was led by senior author Dr. Amy Kuceyeski and doctoral student Parker Singleton, with the help of researchers at Weill Cornell Medicine and Imperial College of London. The scientists are interested in finding therapeutic use for the substances, and may have established a new way to evaluate the effects of psychoactive drugs on a broad scale.
In the study, researchers tracked the effects of LSD and psilocybin on brain activity using functional magnetic resonance imaging (fMRI) recordings of the brain activity of volunteers. Each volunteer underwent two scanning sessions. One session included a dose of LSD or psilocybin, the other a placebo.
“Serotonin 2a receptors have a spatial distribution in the brain that appears to be optimized for lowering these state transition energies,” Singleton told the Weill Cornell School of Medicine’s newsroom.
Can magic mushrooms really help with alcoholism?
Data from the recordings revealed that participants could transition between activity states more easily, allowing “for more facile state transitions and more temporally diverse brain activity.” The authors added, “more broadly, we demonstrate that receptor-informed network control theory can model the impact of neuropharmacological manipulation on brain activity dynamics.”
The research team now plans to use the same approach to study longer-term effects of LSD and psilocybin on brain dynamics, including those that could be used in clinical settings. They also believe their approach could well improve our subjective understanding of individual psychedelic trips.
“If we want someday to use psychedelic drugs clinically,” Singleton said, “we should understand not only how they’re impacting brain cells, but also how they’re impacting the wider dynamics of brain activity.”
Their new approach, which they dubbed network control theory, uses a clustering algorithm to categorize a data set that represents a network’s activities as distinct patterns, or states. In the study, the meta-view of the network’s state-to-state transitions illustrated that psychedelics lowered, or ‘flattened,’ the minimum energy barriers required to transition between states, “allowing the brain to transition from one state to another much more readily,” according to the results.
Star Buds IL became the first social equity craft marijuana grower to begin operations in Illinois.
The Rockford, Illinois, company, which is 66% Black-owned, on Monday also became the first “licensed predominantly Black-owned cannabis business” in the state, the Chicago Tribune reported.
The opening came after Star Buds IL was issued an operational permit by the state Department of Agriculture.
“This is the first of the 342 cannabis licensees issued by the Department in the last year to open their doors, and there are dozens more who will be joining them soon,” Jerry Costello II, director of the agriculture department, said in a news release.
Of the 48 craft grow licenses issued by the agriculture department in July 2022:
- 42% (20) are majority Black-owned.
- 36% (17) are majority white-owned.
- 8% (4) are majority Hispanic-owned.
- 8% are owned by a partnership group.
All the new licenses were issued to social equity applicants.
Social equity applicants are defined as individuals who live in so-called “disproportionately impacted areas.” That encompasses areas with high rates of poverty, joblessness, marijuana-related arrests and convictions.
The full list of craft grower licensees in Illinois is available on the department’s website.
Since 2021, the state has issued 88 craft grow licenses, 54 infuser licenses and 189 transporter licenses.
Those permits are in addition to the 21 existing cultivation centers previously approved under Illinois’ medical marijuana law.
Eight suspected cases of opioid overdoses connected to marijuana have been detected since June.
As the German saying goes, aller anfang ist schwer: All beginnings are hard. Here’s what lies ahead for the country as it prepares to become the first major European weed market by 2024.
When you think of the world’s largest adult-use cannabis market, your mind probably doesn’t go to Europe. But get ready to update your info, because that could change in 2024 if Germany successfully legalizes adult-use cannabis thanks to its population of more than 83 million people.
To get an inside look at the landscape of legalization in Germany, Leafly reached out to Georg Wurth of the German Cannabis Association, Deutscher Hanfverband (DHV), the primary non-governmental organization behind cannabis legalization in Germany.
Wurth is the first professional cannabis legalization lobbyist in Germany. He’s been impacting weed policy as part of his city council since the ’90s, and in 1996, began to “specialize more and more in drug policy reform.”
Today, DHV is the largest cannabis legalization NGO in Europe, with 30 activist groups across major German cities, like Berlin and Hamburg. Wurth also hosts a weekly cannabis policy news show on YouTube and leads DHV in online public debate.
When asked if legalization in Germany is guaranteed in 2024, Wurth’s response is a familiar one from states on the brink of legalization in the US. “Nothing is guaranteed in drug policy reform until it is reality,” he said.
Still, he was optimistic: “Becoming the world’s third [country] to fully legalize cannabis is quite a big story, with a lot of hurdles. I hope we´ll get it done, and I think we can. But how likely? Today, I say 60%,” Wurth told Leafly.
Signs of support from the German people
In 2021, Ipsos conducted a poll in which 61% of Germans said they would support the controlled sale of cannabis in licensed stores, and there are already reports that the German cannabis industry could bring the country more than $5 billion in annual revenue.
Germany, which legalized medical cannabis in 2017, currently has an estimated 128,000 medical cannabis patients. Last year, more than 9,000 kilograms (the equivalent of 19,841+ pounds) of cannabis were imported from countries like Canada, Denmark, and Portugal to be studied or sold at German medical pharmacies to be used for medicinal cannabis products.
This figure was up from around 6,300 pounds the year before, showing that the appetite for medicinal cannabis in Germany continues to grow along with the people’s desire for legal adult-use weed.
Germany’s path to adult-use legalization: What are the obstacles?
The hurdles that the country faces in legalizing recreational cannabis are numerous. The pandemic, an increase in the cost of living, and Russia’s war on Ukraine are all factors that put strain on politicians seeking to legalize weed, like The Social Democrats (SPD), Greens, and Free Democrats (FDP) — a three-party coalition that came into governing power in late 2021, also known as the Traffic Light Coalition,.
Each party of the coalition has unique reasons for supporting the legalization of cannabis, like reducing illicit sales, though the SPD is reportedly the most eager to see strong regulation with legalization.
Still, Wurth notes that one of Germany’s biggest hurdles will be to overcome pushback from cannabis legalization opponents. In the aftermath of former Chancellor Angela Merkel’s departure, the Traffic Light Coalition is eager to bring fresh energy to the country. Merkel served as Chancellor for sixteen years, and her party, the Christian Democrats (CDU), was known for being more conservative in its views on cannabis.
In addition to international laws, Germany also has to grapple with EU regulations, and experts continue to debate whether the EU could put a stop to Germany’s legalization plans.
“Whether or not our top politicians really want [legalization] and if they are ready to have some tensions on the international level, we will see. It’s a narrow game,” said Wurth.
Positive outlooks on pot
As for leading the way in Europe and the EU, Wurth believes there’s “no doubt” that Germany will inspire other countries to legalize recreational cannabis.
“Germany could become the first nation to legalize outside of the Americas. That will bring a big additional momentum not only for Europe, but for the rest of the world!”
What’s certain, Wurth claims, is that there are millions of Germans who love weed and who already accept it as part of their lives.
“I say, we have at least four million people who consumed cannabis in the last 12 months. Some smoked one day, some smoke 365. They do all kinds of things with their lives while being cannabis consumers. Two or three times I was asked, do you come from the cannabis scene? I said, I come from the tax officer scene, from the Green Party scene, from the youth scene. That all makes as much sense as the cannabis scene for me.”
Former Southern California politician Jermaine Wright was sentenced to five years in a federal prison after being convicted of bribery in a marijuana business licensing scheme as well as attempted arson.
Wright, who was mayor pro tem and a city councilor in Adelanto, California, was arrested and charged in 2017 with soliciting and accepting a $10,000 bribe from an undercover FBI agent to help in obtaining a license to open a marijuana transportation business.
The 46-year-old also was charged with paying a different undercover FBI agent $1,500 to burn down his restaurant for the insurance payout, the Associated Press reported.
Wright, who pleaded not guilty to the charges, received the minimum five-year sentence, according to the AP.
He is part of a growing list of local officials involved in corruption practices related to the marijuana industry.
In 2021, for example, then-Adelanto Mayor Richard Kerr was indicted by federal prosecutors for allegedly taking nearly $60,000 in bribes and kickbacks related to marijuana business licensing.
Cauda Equina Syndrome causes so many troubling symptoms from sleep disorders, and severe pain, to muscle spasms and spasticity that many patients seek alternative options to manage their symptoms. But as CBD and Cannabis are not currently FDA approved for use in the medical management of cauda equina syndrome, there is limited guidance on their uses- leaving patients and providers to rely on a trial and error approach. Unfortunately, this can lead to expensive failed therapy. With the proper education, it may be possible for healthcare providers to adequately guide their patients to more effective use of Cannabis and CBD.
Cauda Equina Foundation serves to improve the quality of life and care for individuals living with cauda equina syndrome and associated disorders. This channel serves that mission by meeting our educational goals.
From time to time the Foundation may update or remove videos to reflect the Foundation’s Medical Advisory, Scientific, & Review Board’s latest research findings in order to provide the highest quality and latest educational materials available on CES.
Cauda Equina Syndrome is a complex medical condition. This presentation is for educational purposes and provides only a general overview of Cauda Equina Syndrome and has been designed to be simple and accessible. Accordingly, this presentation may omit terms or concepts relevant to specific circumstances and does not constitute professional medical advice. Use of, and access to, this presentation or any of the links or resources contained herein do not create a doctor-patient relationship between you and Cauda Equina Foundation, Inc.
Please do not act or refrain from acting based on anything in this presentation without first seeking medical advice from your healthcare providers. Only your licensed healthcare providers can provide assurances that the information contained herein, and your interpretation of it, is appropriate to your particular situation.
Cauda Equina Foundation, Inc., is not responsible for any harm that results from the reliance on any information contained in this presentation.
The views reflected in third-party presenters do not necessarily reflect the view of Cauda Equina Foundation, Inc.